The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody therapy in patients with relapsed refractory multiple myeloma (RRMM).
Abhishek Janardan
No Relationships to Disclose
Hammons Lindsay
No Relationships to Disclose
Aniko Szabo
No Relationships to Disclose
Vineel Bhatlapenumarthi
No Relationships to Disclose
Evanka Annyapu
No Relationships to Disclose
Binod Dhakal
Honoraria - Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Amgen; Arcellx; Genentech/Roche; GlaxoSmithKline; Janssen Oncology; Natera; Pfizer; Sanofi; Takeda
Speakers' Bureau - Janssen Oncology
Research Funding - Amgen (Inst); Arcellx (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Sanofi (Inst)
Ravi Kishore Narra
No Relationships to Disclose
Samer Al Hadidi
Honoraria - Janssen; Sanofi
Sabarinath Venniyil Radhakrishnan
No Relationships to Disclose
Divaya Bhutani
Consulting or Advisory Role - Sanofi
Research Funding - Sanofi (Inst)
Sharmilan Thanendrarajan
No Relationships to Disclose
Janz Siegfried
No Relationships to Disclose
Maurizio Zangari
No Relationships to Disclose
Suzanne Lentzsch
Leadership - Caelum Biosciences
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Adaptive Biotechnologies; BMS; GlaxoSmithKline; Janssen; Natera; Oncopeptides; Pfizer; Sanofi; Takeda
Speakers' Bureau - BioAscent; Clinical Care Options; PeerView;
Research Funding - Sanofi
Patents, Royalties, Other Intellectual Property - Patent 11-1F4 mAb for use in AL Amyloidosis
Frits van Rhee
Consulting or Advisory Role - Celgene; GlaxoSmithKline; Janssen Biotech; Sanofi; Takeda
Anita D'Souza
Consulting or Advisory Role - Akcea Therapeutics; Bristol-Myers Squibb/Celgene; Janssen Oncology; Pfizer; Prothena
Research Funding - Abbvie (Inst); Caelum Biosciences (Inst); Janssen Oncology (Inst); Prothena (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Imbrium Therapeutics
Rajshekhar Chakraborty
Consulting or Advisory Role - Adaptive Biotechnologies; Janssen; Sanofi Pasteur
Carolina D. Schinke
No Relationships to Disclose
Meera Mohan
Consulting or Advisory Role - Sanofi
Research Funding - Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Takeda